Preparation and evaluation of mouth dissolving tablets of meloxicam
Keywords:
Mouth dissolving tablet, Maloxicam, Bioavailability, NSAIDAbstract
The aim of the present study was to develop evaluate mouth dissolving tablet of meloxicam. Drug delivery systems became sophisticated as pharmaceutical scientists acquire a better understanding of the physicochemical and biochemical parameters pertinent to their performance. Over the past three decades, mouth dissolving or orally disintegrating tablets have gained considerable attention as a preferred alternative to conventional tablets due to better patient compliance. The most preferrable route of drug administration (e.g. oral) is limited to drug candidate that show poor permeability across the gastric mucosa and those, which are sparingly soluble. A large majority of the new chemical entities and many new existing drug molecules are poorly soluble, thereby limiting their potential uses and increasing the difficulty of formulating bioavailable drug products,so lastlly the purpose of this study was to grow mouth dissolve tablets of Meloxicam. Meloxicam is a newer selective COX-1 inhibitor. These tablets were prepared by wet granulation procedure. The tablets were evaluated for % friability, wetting time and disintegration time. Sublimation of camphor from tablets resulted in better tablets as compared to the tablets prepared from granules that were exposing to vacuum. The systematic formulation approach helped in understanding the effect of formulation processing variables.
References
Birudaraj R, Berner B, Shen S, Li X. Buccal
permeation of buspirone: mechanistic studies on
transport pathways. J Pharm Sci. 2005;94:70-78.
Ishikawa T, Koizumi N, Mukai B. Pharmacokinetics of acetaminophen from rapidly disintegrating
compressed tablet prepared using microcrystalline
cellulose (PH-M-06) and spherical sugar
granules. Chem. Pharm Bull (Tokyo). 2001;49:230-
Price T.M., Blauer K.L., Hansen M., Stanczyk F., L
obo R., Bates G.W. Single-dose pharmacokinetics
of sublingual versus oral administration of
micronized17-beta-estradiol. Obstet Gynecol. 1997;
:340-345.
Habib,W., Khankari, R., Hontz, J. Fast-dissolving
drug delivery systems, critical review in
therapeutics, Drug Carrier Systems, 2000;17:61-72.
Chang, R., Guo, X., Burnside, B. A., Couch, R.
Fast-dissolving tablets, Pharm. Tech., 2000; 24:52-
Dobetti, L. Fast-Melting Tablets: Developments
and Technologies, Pharm. Tech., (Suppl.), 2001;
-50.
Corveleyn. S, Remon JP. Formulation and
production of rapidly disintegrating tablets by
lyophilization using hydrochlorothiazide as a model
drug. Int J Pharm. 1997;152: 215-225.
Remon JP, Corveleyn S. Freeze-dried rapidly
disintegrating tablets. US patent 6 010 719. January
, 2000.
Heinemann H, Rothe W. Preparation of porous
tablets. US patent 3 885 026. May 20, 1975.
Knistch A, Hagen E, Munz HD. Production of
porous tablets. US patent 4 134 843, January 16,
Roser BJ, Blair J. Rapidly soluble oral dosage
forms, method of making same, and composition
thereof. US patent 5 762 961. June 9, 1998.
Wallace JL. Prostaglandins, NSAIDs and
cytoprotection. Gastroenterol Clin. North Am.
;21: 631-641.
Troy M.Harmon .Beyond the first generations of
orally disintegrating Tablets. Emerging technology.
Tablets and Capsules, 3 Sep 2006.
Gothoskar, A.V., Parakh, S.R. A Review of mouth
dissolving tablet technologies. (Drug Delivery).
Pharmaceutical Technology.(Nov01/2003)
William R.P., Tapash .K. Ghosh. Orally
disintegrating tablets. Pharmaceutical Technology
(Product, Technologies, and Development issues in
Oct 2005).
Wayne C., Dipan R., Ann D. Selecting
superdisintegrants for Orally Disintegrating Tablet
Formulations in Phrmaceutical Technology Oct
/2006.
Jadon,R.S., Vaidya V.D., Khemariya P., Nayak S.
Taste Masking of Lornoxicam by Polymer Carrier
System and Formulation of Oral Disintegrating
Tablets. IJDD 2009; 1: 1-3